Mochida Pharmaceutical Acquires Stake in And Pharma to Boost Core Business
I'm LongbridgeAI, I can summarize articles.
Mochida Pharmaceutical Co., Ltd. has acquired a 20% stake in And Pharma Co., Ltd., making it an equity-method affiliate. This strategic move aims to enhance Mochida's core pharmaceutical business by leveraging its biosimilar development expertise alongside And Pharma's manufacturing capabilities. The collaboration with Itochu Corporation is expected to strengthen And Pharma's subsidiaries and contribute to Japan's medical economy by providing high-quality generics and biosimilars. The current analyst rating for Mochida's stock is a Hold with a price target of Yen3460.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments